Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening

• Published in: JNCI : Journal of the National Cancer Institute 2022-02, Vol.114 (2), p.254-262
• Main Authors: Pan, I-Wen, Oeffinger, Kevin C, Shih, Ya-Chen Tina
• Format: Article
• Language: English
• Subjects: Breast cancer; Breast Neoplasms - diagnostic imaging; Breast Neoplasms - prevention & control; Cancer screening; Consumer-driven health plans; Costs; Early Detection of Cancer; Female; Health Expenditures; Humans; Magnetic Resonance Imaging; Mammography; Medical screening; Patient Protection & Affordable Care Act 2010-US; Patient Protection and Affordable Care Act; Regression models; United States - epidemiology
• ISSN: 0027-8874; 1460-2105
• DOI: 10.1093/jnci/djab150

Abstract Background The financial protection of the prevention provision of the Affordable Care Act (ACA) doesn’t apply to breast MRI but only to mammography for breast cancer screening. The purpose of the study is to examine the financial burden among women who received breast magnetic resonance imaging (MRI) for screening. Methods This observational study used the Marketscan database. Women who underwent breast MRI between 2009 and 2017 and had screening mammography within 6 months of the MRI were included. We compared the time trend of the proportion of zero cost-share for women undergoing screening mammography and that for MRI. We quantified out-of-pocket (OOP) costs as the sum of copayment, coinsurance, and deductible and defined zero cost-share as having no OOP cost. We conducted multivariable logistic regression and 2-part model to examine factors associated with zero cost-share and OOP costs of MRI, respectively. Results During the study period, 16 341 women had a screening breast MRI. The proportion of screening MRI claims with zero cost-share decreased from 43.1% (2009) to 26.2% (2017). The adjusted mean OOP cost for women in high-deductible plans was more than twice the cost for their counterparts ($549 vs $251; 2-sided P